Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
Blood Coagul. Fibrinolysis., Sep;21(6):534-8 (2010)
The antiphospholipid syndrome.
Annu. Rev. Med., 54:409-24 (2003)
Molecular pathogenesis of the antiphospholipid syndrome.
Circ. Res., Jan;90(1):29-37 (2002)
The pathogenic role of annexin-V in the antiphospholipid syndrome.
Curr Rheumatol Rep., Jun;2(3):246-51 (2000)
The annexinopathies: a new category of diseases.
Biochim. Biophys. Acta., Dec;1498(2-3):169-73 (2000)
Antiphosphatidyl serine antibodies are independently associated with ischemic stroke.
Neurology., Oct;53(7):1523-7 (1999)
Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.
Am. J. Med. Sci., Aug;316(2):142-51 (1998)
In vitro studies of the interactions between platelets and amniotic membranes: a potential treatment for preterm premature rupture of the membranes.
Am. J. Obstet. Gynecol., Feb;178(2):287-93 (1998)
Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.
Am. J. Obstet. Gynecol., Oct;177(4):918-23 (1997)
Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
N. Engl. J. Med., Jul;337(3):154-60 (1997)
The significance of subendothelial von Willebrand factor.
Thromb. Haemost., Jul;78(1):445-50 (1997)
Renal allograft thrombosis associated with the antiphospholipid antibody syndrome.
Transplantation., Sep;60(6):614-5 (1995)
Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies.
Thromb. Res., Feb;85(3):177-83 (1997)
Reduced thrombogenicity of type VI collagen as compared to type I collagen.
Thromb. Res., Sep;79(5-6):429-36 (1995)
The immunobiology and obstetrical consequences of antiphospholipid antibodies.
Obstet Gynecol Surv., Jun;49(6):432-41 (1994)
An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases.
J. Rheumatol., Jul;21(7):1360-4 (1994)
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.
Placenta., Sep;15(6):601-12 (1994)
Alterations of platelet function induced by interleukin-2.
J. Immunother., Oct;10(5):363-70 (1991)
Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium.
Am. J. Pathol., Mar;142(3):843-50 (1993)
Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures.
J. Cardiothorac. Vasc. Anesth., Apr;5(2):142-5 (1991)
150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.
J. Clin. Invest., Jul;88(1):253-9 (1991)
Preoperative evaluation of hematologic status.
Mt. Sinai J. Med., Jan;58(1):41-7 (1991)
Effects of endotoxin on iron uptake by the hepatocyte.
Am. J. Physiol., Oct;257(4 Pt 1):G524-31 (1989)
Unusual venous thrombosis associated with protein C deficiency.
J. Vasc. Surg., Mar;7(3):443-5 (1988)
Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature.
Am. J. Med., Dec;85(6):861-3 (1988)
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut.
Biochem. Biophys. Res. Commun., Nov;148(3):1370-6 (1987)
In vitro multimerization of human von Willebrand factor from its subunits.
Br. J. Haematol., Dec;67(4):433-6 (1987)
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.
Am. J. Obstet. Gynecol., Dec;171(6):1566-72 (1994)
Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
Am. J. Obstet. Gynecol., Dec;205(6):576.e7-14 (2011)
Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.
J. Rheumatol., Feb;39(2):382-8 (2012)
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
Blood., Sep;112(5):1687-95 (2008)
Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Blood., Mar;115(11):2292-9 (2010)
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Lupus., Apr;19(4):460-9 (2010)
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Thromb. Haemost., May;95(5):886-92 (2006)
Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls.
Am. J. Obstet. Gynecol., Oct;195(4):971-8 (2006)
An evaluation of thrombophilia screening in an urban tertiary care medical center: A "real world" experience.
Am. J. Clin. Pathol., Jul;126(1):120-7 (2006)
The antiphospholipid syndrome.
Hematology Am Soc Hematol Educ Program., 136-42 (2007)
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.
Blood., Nov;104(9):2783-90 (2004)
Antibody-mediated interference with annexins in the antiphospholipid syndrome.
Thromb. Res., 114(5-6):383-9 (2004)
Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses.
Am. J. Obstet. Gynecol., Jan;194(1):182-8 (2006)
Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction.
Am. J. Obstet. Gynecol., May;194(5):1371-6 (2006)
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
Am. J. Pathol., Sep;163(3):1193-200 (2003)
Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mt. Sinai J. Med., Oct;70(5):344-51 (2003)
Seasonal distribution of antiphospholipid antibodies.
Stroke., Aug;32(8):1707-11 (2001)
Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
J. Autoimmun., Sep;15(2):107-11 (2000)
Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome.
Thromb. Haemost., Aug;82(2):649-55 (1999)
Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.
Stroke., Aug;30(8):1561-5 (1999)
Thrombophilias: diagnosis and treatment of thrombophilia relating to contraception and pregnancy.
Semin. Hematol., Jul;36(3 Suppl 4):2-9 (1999)
Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
Blood., Sep;92(5):1652-60 (1998)
von Willebrand factor binding to collagen in patients with end-stage renal disease.
J. Lab. Clin. Med., Jan;123(1):137-42 (1994)
Modest doses of nitroglycerin do not interfere with beef lung heparin anticoagulation in patients taking nitrates.
J. Cardiothorac. Vasc. Anesth., Dec;6(6):677-9 (1992)
Official communication of the scientific and standardization committee on lupus anticoagulant/phospholipid-dependent antibodies: update of the guidelines for lupus anticoagulant detection
Journal of Thrombosis and Haemostasis
Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers
Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome
Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5